146 related articles for article (PubMed ID: 8380533)
1. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis.
Palazzo JP; Lundquist K; Mitchell D; Mittal KR; Hann HW; Munoz S; Moritz MJ; Jacobs JM; Martin P
Am J Gastroenterol; 1993 Jan; 88(1):102-4. PubMed ID: 8380533
[TBL] [Abstract][Full Text] [Related]
2. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
3. Case report: fatal lymphoproliferative disease seven weeks after liver transplantation.
Hoon V; Fasy TM; Kheiri S; Theise N; Lin CS; Klion F; Schwartz M; Miller C; Thung SN
Mt Sinai J Med; 1994 Jan; 61(1):72-6. PubMed ID: 8183298
[TBL] [Abstract][Full Text] [Related]
4. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
7. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
[TBL] [Abstract][Full Text] [Related]
8. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
9. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
Seyam M; Neuberger JM; Gunson BK; Hübscher SG
Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
[TBL] [Abstract][Full Text] [Related]
10. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.
Segovia R; Sánchez-Fueyo A; Rimola A; Grande L; Bruguera M; Costa J; Soguero C; Uriz J
Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393
[TBL] [Abstract][Full Text] [Related]
11. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
[TBL] [Abstract][Full Text] [Related]
12. Allograft biopsies in situ hybridization HBVDNA detection of serum HBs Ag-repositive patients treated with anti-HBV immunoprophylaxis after liver transplantation for HBV cirrhosis.
Reynès M; Tricottet V; Samuel D; Sebagh M; Bismuth A; Arulnaden J; Brechot C; Bismuth H
Transplant Proc; 1993 Feb; 25(1 Pt 2):1347-8. PubMed ID: 8442139
[No Abstract] [Full Text] [Related]
13. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.
Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T
Transplant Proc; 1996 Jun; 28(3):1714-6. PubMed ID: 8658852
[No Abstract] [Full Text] [Related]
14. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
[TBL] [Abstract][Full Text] [Related]
15. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
Lucena JF; Herrero JI
An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
[TBL] [Abstract][Full Text] [Related]
16. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
Ward SC; Chang CY; Peng L; Liu LU
Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
[TBL] [Abstract][Full Text] [Related]
18. Disease recurrence following liver transplantation.
Hart J; Busuttil RW; Lewin KJ
Am J Surg Pathol; 1990; 14 Suppl 1():79-91. PubMed ID: 2109546
[TBL] [Abstract][Full Text] [Related]
19. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
20. Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B.
Lisker-Melman M; Pittaluga S; Pluda JM; Kleiner DE; Thompson P; Martin P; Yarchoan R; Di Bisceglie AM
Am J Gastroenterol; 1989 Nov; 84(11):1445-8. PubMed ID: 2683745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
